Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05294900
What this trial is testing

Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 79
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175636
What this trial is testing

QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Mismatch Repair-Proficient (pMMR) Rectal CancerNon-metastatic Rectal Cancer
Sun Yat-sen University 66
Large-scale testing (Phase 3)Study completedNCT01500993
What this trial is testing

Capecitabine in the Perioperative Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer
Universitätsmedizin Mannheim 401
Testing effectiveness (Phase 2)Study completedNCT00551421
What this trial is testing

Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)WithdrawnNCT01345084
What this trial is testing

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab

Who this might be right for
CarcinomaHead and Neck Cancer
Eurofarma Laboratorios S.A.
Testing effectiveness (Phase 2)Ended earlyNCT01192815
What this trial is testing

Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+9 more
Case Comprehensive Cancer Center 2
Large-scale testing (Phase 3)Looking for participantsNCT06899126
What this trial is testing

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Daiichi Sankyo 686
Testing effectiveness (Phase 2)Study completedNCT05219435
What this trial is testing

Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Urothelial Cancer
Spanish Oncology Genito-Urinary Group 25
Testing effectiveness (Phase 2)Study completedNCT03406299
What this trial is testing

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
National Health Research Institutes, Taiwan 92
Testing effectiveness (Phase 2)Study completedNCT03104699
What this trial is testing

AGEN2034 in Advanced Tumors and Cervical Cancer

Who this might be right for
Advanced CancerCervical Cancer
Agenus Inc. 211
Early research (Phase 1)Study completedNCT02935309
What this trial is testing

Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma

Who this might be right for
Rectal CancerRectal Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05668858
What this trial is testing

SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Sichuan Baili Pharmaceutical Co., Ltd. 70
Testing effectiveness (Phase 2)Looking for participantsNCT06093438
What this trial is testing

Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerInduction ChemotherapyImmunotherapy
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00589238
What this trial is testing

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 16
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Early research (Phase 1)Study completedNCT03307148
What this trial is testing

Stromal TARgeting for PAncreatic Cancer (STAR_PAC)

Who this might be right for
Pancreatic Adenocarcinoma
Barts & The London NHS Trust 29
Large-scale testing (Phase 3)UnknownNCT04426955
What this trial is testing

Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT04989855
What this trial is testing

Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score

Who this might be right for
Locally Advanced Rectal Cancer
Sun Yat-sen University 48
Testing effectiveness (Phase 2)Ended earlyNCT03184558
What this trial is testing

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC

Who this might be right for
Triple Negative Breast CancerInflammatory Breast Cancer Stage IV
BerGenBio ASA 29
Next Page